TXG vs. META
TXG (10x Genomics, Inc.) and META (Meta Platforms, Inc.) are both stocks. TXG operates in Health Information Services (Healthcare), while META operates in Internet Content & Information (Communication Services). Over the past 5 years, TXG returned -29.15%/yr vs 13.70%/yr for META. At a 0.32 correlation, their price movements are largely independent.
Performance
TXG vs. META - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TXG achieves a 97.18% return, which is significantly higher than META's -5.54% return.
TXG
- 1D
- 4.72%
- 1M
- 48.55%
- YTD
- 97.18%
- 6M
- 79.97%
- 1Y
- 253.02%
- 3Y*
- -16.17%
- 5Y*
- -29.15%
- 10Y*
- —
META
- 1D
- 4.24%
- 1M
- 2.06%
- YTD
- -5.54%
- 6M
- -2.44%
- 1Y
- -6.29%
- 3Y*
- 32.06%
- 5Y*
- 13.70%
- 10Y*
- 18.15%
TXG vs. META - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
TXG 10x Genomics, Inc. | 97.18% | 13.58% | -74.34% | 53.57% | -75.54% | 5.20% | 85.70% | 44.55% |
META Meta Platforms, Inc. | -5.54% | 13.09% | 66.05% | 194.13% | -64.22% | 23.13% | 33.09% | 9.48% |
Correlation
The correlation between TXG and META is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.35 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2019 | 0.32 |
The correlation between TXG and META shifts across timeframes, from 0.20 (1 year) to 0.35 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
TXG:
$4.13B
META:
$1.60T
TXG:
-$0.18
META:
$27.47
TXG:
6.36
META:
7.45
TXG:
5.07
META:
6.55
TXG:
$638.78M
META:
$214.96B
TXG:
$444.61M
META:
$176.14B
TXG:
-$5.89M
META:
$106.31B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TXG vs. META — Risk / Return Rank
TXG
META
TXG vs. META - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for 10x Genomics, Inc. (TXG) and Meta Platforms, Inc. (META). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TXG | META | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.99 | ||
| Sortino ratioReturn per unit of downside risk | +3.92 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 1.00 | +0.45 |
| Calmar ratioReturn relative to maximum drawdown | 9.15 | -0.19 | +9.34 |
| Martin ratioReturn relative to average drawdown | 21.17 | -0.41 | +21.58 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| TXG | META | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.81 | -0.18 | +3.99 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.43 | 0.31 | -0.74 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.47 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.11 | 0.56 | -0.66 |
Drawdowns
TXG vs. META - Drawdown Comparison
The maximum TXG drawdown since its inception was -96.47%, which is greater than META's maximum drawdown of -76.74%. Use the drawdown chart below to compare losses from any high point for TXG and META.
Loading charts...
Drawdown Indicators
| TXG | META | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.47% | -76.74% | -19.73% |
Max Drawdown (1Y)Largest decline over 1 year | -28.03% | -33.30% | +5.27% |
Max Drawdown (3Y)Largest decline over 3 years | -88.66% | -34.15% | -54.51% |
Max Drawdown (5Y)Largest decline over 5 years | -96.45% | -76.74% | -19.71% |
Max Drawdown (10Y)Largest decline over 10 years | — | -76.74% | — |
Current DrawdownCurrent decline from peak | -84.11% | -20.96% | -63.15% |
Average DrawdownAverage peak-to-trough decline | -59.62% | -15.25% | -44.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.08% | 15.47% | -3.39% |
Volatility
TXG vs. META - Volatility Comparison
10x Genomics, Inc. (TXG) has a higher volatility of 16.46% compared to Meta Platforms, Inc. (META) at 8.84%. This indicates that TXG's price experiences larger fluctuations and is considered to be riskier than META based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TXG | META | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.46% | 8.84% | +7.62% |
Volatility (6M)Calculated over the trailing 6-month period | 45.64% | 26.58% | +19.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 67.46% | 35.23% | +32.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 68.25% | 43.99% | +24.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 66.73% | 38.64% | +28.09% |
Dividends
TXG vs. META - Dividend Comparison
TXG has not paid dividends to shareholders, while META's dividend yield for the trailing twelve months is around 0.34%.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
META Meta Platforms, Inc. | 0.34% | 0.32% | 0.34% |
TXG 10x Genomics, Inc. | 0.00% | 0.00% | 0.00% |
Financials
TXG vs. META - Financials Comparison
This section allows you to compare key financial metrics between 10x Genomics, Inc. and Meta Platforms, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TXG vs. META - Profitability Comparison
TXG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, 10x Genomics, Inc. reported a gross profit of 106.18M and revenue of 150.84M. Therefore, the gross margin over that period was 70.4%.
META - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported a gross profit of 46.09B and revenue of 56.31B. Therefore, the gross margin over that period was 81.9%.
TXG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, 10x Genomics, Inc. reported an operating income of -17.05M and revenue of 150.84M, resulting in an operating margin of -11.3%.
META - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported an operating income of 22.87B and revenue of 56.31B, resulting in an operating margin of 40.6%.
TXG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, 10x Genomics, Inc. reported a net income of -13.47M and revenue of 150.84M, resulting in a net margin of -8.9%.
META - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported a net income of 26.77B and revenue of 56.31B, resulting in a net margin of 47.5%.
Frequently Asked Questions
TXG and META have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TXG has higher volatility (16.46%) compared to META (8.84%). In terms of maximum drawdown, TXG dropped -96.47% vs META's -76.74%.
TXG currently has the higher Sharpe Ratio (3.81 vs -0.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TXG and META
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer